Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Operating Expenses | 6,361 | 8,500 | 5,116 | 4,569 | 4,028 |
| Operating Income | -6,361 | -8,500 | -5,116 | -4,569 | -4,028 |
| Other Income | -5,490 | -3,705 | 14,155 | -13,084 | 4,992 |
| Pre-tax Income | -11,851 | -12,205 | 9,039 | -17,653 | 964 |
| Net Income Continuous | -11,851 | -12,205 | 9,039 | -17,653 | 964 |
| Net Income | $-11,851 | $-12,205 | $9,039 | $-17,653 | $964 |
| EPS Basic Total Ops | -32.98 | -38.98 | 31.48 | -65.97 | 10.49 |
| EPS Basic Continuous Ops | -33.96 | -38.58 | 31.99 | -65.92 | 10.56 |
| EPS Diluted Total Ops | -29.99 | -38.98 | 28.49 | -65.97 | 10.49 |
| EPS Diluted Continuous Ops | -29.73 | -38.58 | 27.76 | -65.92 | 10.56 |
| EBITDA(a) | $-6,326 | $-8,463 | $-5,067 | $-4,502 | $-3,950 |